Related Experiment Videos
The fibrinolytic system in man
Critical Reviews in Oncology/Hematology
|January 1, 1984
Summary
The human body has a natural system for dissolving blood clots, regulated by plasminogen activators and inhibitors. This plasminogen-plasmin system can be therapeutically targeted to treat various thrombotic diseases.
Area of Science:
- Biochemistry
- Physiology
- Hematology
Background:
- The human body possesses an endogenous system for dissolving pathological thrombi.
- Understanding the regulation of this system is crucial for treating thrombotic diseases.
Purpose of the Study:
- To elucidate the physiological regulation of plasmin formation.
- To review the therapeutic applications of the plasminogen-plasmin system.
Main Methods:
- Review of existing data on plasminogen regulation.
- Analysis of factors controlling the synthesis of proteolytic enzymes.
- Examination of therapeutic agents targeting the plasminogen-plasmin system.
Main Results:
- Plasmin formation depends on plasminogen concentration, activator availability, inhibitors, and fibrin.
- The plasminogen-plasmin system can be therapeutically utilized.
- Exogenous agents can dissolve thrombi in venous and arterial systems.
Conclusions:
- The plasminogen-plasmin system offers therapeutic potential for all thrombotic diseases.
- Targeting this system can reverse the pathological effects of thrombosis.
- Innovations enable advantageous employment of the plasminogen system for thrombotic conditions.